Darolutamide in nonmetastatic, castration-resistant prostate cancer

Research output

Research output per year 2022 2022 2022

• 824 Citations
• 1 Erratum

Research output per year

Research output per year

Search results

• 2022

  Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer (N Engl J Med 2019;380:1235-1246): Correction

  Fizazi, K., Shore, N., Tammela, T., Ulys, A., Vjaters, E., Polyakov, S., Jievaltas, M., Luz, M., Alekseev, B., Kuss, I., Kappeler, C., Snapir, A., Sarapohja, T. & Smith, M., 1 Sept 2022, In: New England Journal of Medicine. 387, 9, p. 860-860 1 p.

  Research output: Contribution to journal › Erratum